Clinical Trial Update: Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and immunogenicity study of a tetravalent rotavirus vaccine sponsored by Shantha Biotechnics Limited; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Tetravalent Rotavirus Vaccine (tetravalent rotavirus vaccine)

Snippet

Sponsor: Shantha Biotechnics Limited | Conditions: Rotavirus Gastroenteritis | Phase 1, Phase 2 | Status: UNKNOWN